Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Lilly Pays $35m Up Front To Access Lyci
A collaboration to develop a plant-derived ‘bio-better’ rituximab candidate for the Chinese market between iBio , a US leader in plant-based technology, and China’s CC-Pharming, a plant molecular med
Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Below is a roundup of some of the most noteworthy recent transactions. Deal Watch is supported by deal in
IN VITRO DIAGNOSTICS Alliances AEterna Zentaris Inc. Roche Ventana Medical Systems Inc. In one of two companion diagnostics deals it signed on the same day, Roche Diagnostics Corp. ’s Ventana Med